Zenith Healthcare

Zenith Healthcare EBIT Margin

The EBIT Margin (Operating Margin) of Zenith Healthcare (530665.BO) as of Oct 17, 2026 is -1.99 %. In the previous year, EBIT Margin (Operating Margin) was -1.24 % — a change of 61.12% (lower).

EBIT Margin

-1.99 %

YoY

61.12%

Last updated:

EBIT Margin (Operating Margin) of Zenith Healthcare is 2026 -1.99 % . EBIT Margin (Operating Margin) of Zenith Healthcare was 2025 -1.24 % . It decreases by 61.12% lower compared to the previous year.

Zenith Healthcare's operating (EBIT) margin stands at -2.0%, down from 0.4% several years earlier.

The Zenith Healthcare EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
-0.37 INR
Jan 1, 2020
2.43 INR
Jan 1, 2021
1.63 INR
Jan 1, 2022
0.44 INR
Jan 1, 2023
-1.83 INR
Jan 1, 2024
0.28 INR
Jan 1, 2025
-1.24 INR
Jan 1, 2026
-1.99 INR
The Zenith Healthcare EBIT Margin history
YEAREBIT MarginYoY
-1.99 %+61.12%
-1.24 %-537.85%
0.28 %-115.48%
-1.83 %-517.99%
0.44 %-73.27%
1.63 %-32.86%
2.43 %-758.14%
-0.37 %-112.67%
2.92 %-166.26%
-4.40 %-74.06%
-16.98 %+59.27%
-10.66 %-25.30%
-14.27 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zenith Healthcare Stock analysis

What does Zenith Healthcare do? Zenith Healthcare Ltd is an Indian pharmaceutical company headquartered in Ahmedabad, Gujarat. The firm engages in the manufacture of pharmaceutical formulations, producing products in various dosage forms including tablets, capsules, oral liquids, and injections. Zenith Healthcare offers its products across a diverse range of therapeutic segments, covering areas such as antibiotics and anti-infectives, gastrointestinal tract disorders, analgesic and anti-inflammatory treatments, cardiovascular system conditions, respiratory issues, ophthalmology, biotechnical products, oncology, anti-retroviral therapies, central nervous system disorders, nutrition, genito-urinary system ailments, and skin conditions. Specific products within the antibiotics and anti-infective category include Roxythromycin Tablets, Ciprofloxacin Tablets, Azithromycine Dihydrate Suspension, and Azithromycin Oral Suspension. In the gastrointestinal segment, the company provides Ranitidine Hydrochloride Tablets. For the cardiovascular system, Lisinopril Tablets are part of its portfolio. The analgesic category features Paracetamol and Aceclofenac Tablets. Additionally, the company offers contract manufacturing services for all dosage forms, catering to broader industry needs. Zenith Healthcare Ltd went public on April 27, 1995, with the ticker symbol 530665.BO and ISIN INE812B01026. The company's official website is https://www.zenithhealthcare.com/. As a player in the health care sector, specifically within the pharmaceuticals industry, Zenith Healthcare Ltd contributes to the availability of essential medicines across multiple therapeutic areas. Its manufacturing capabilities and wide product range allow it to serve various market demands, from generic formulations to specialized treatments. The company's presence in Ahmedabad positions it within a significant industrial hub in India, facilitating its operational and logistical activities. Through its comprehensive product portfolio and contract manufacturing services, Zenith Healthcare Ltd aims to meet the healthcare needs of patients and partners alike, maintaining a focus on quality and efficacy in its pharmaceutical offerings. The company's public listing since 1995 reflects its established presence in the financial markets, providing investors with exposure to the Indian pharmaceutical sector. Its diverse therapeutic coverage underscores its commitment to addressing a broad spectrum of medical conditions, from common infections to complex chronic diseases. This strategic positioning enables Zenith Healthcare Ltd to remain competitive in the dynamic pharmaceutical landscape, adapting to evolving healthcare requirements and regulatory standards in India and potentially beyond. Zenith Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zenith Healthcare stock

EBIT Margin (Operating Margin) of Zenith Healthcare is -1.99 % in 2026.

EBIT Margin (Operating Margin) of Zenith Healthcare changed from -1.24 % to -1.99 %, representing a 61.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Zenith Healthcare since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Zenith Healthcare with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Zenith Healthcare

All Key Metrics — Zenith Healthcare